Long-Term Consequences of High Titer Neutralizing Antibodies to Interferon-β in Multiple Sclerosis
BackgroundNeutralizing anti-drug antibodies (NAbs) to interferon beta (IFNβ) develop in up to 47% of multiple sclerosis (MS) treated patients inhibiting treatment effect of IFNβ. However, the long-term effect of NAbs remain unknown.ObjectiveTo investigate the long-term consequences of high titer NAb...
Збережено в:
| Автори: | , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Frontiers Media S.A.
2020-10-01
|
| Серія: | Frontiers in Immunology |
| Предмети: | |
| Онлайн доступ: | https://www.frontiersin.org/article/10.3389/fimmu.2020.583560/full |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|